Overview

Idiopathic intracranial hypertension (IIH) happens when pressure inside the skull rises without a clear cause. IIH also is called pseudotumor cerebri (SOO-doe-too-mur SER-uh-bry). The higher intracranial pressure can lead to headaches, vision changes and a whooshing sound in the ears. Healthcare professionals can confirm the diagnosis with eye exams and brain imaging. Treatment aims to lower the pressure, protect vision and ease symptoms.

Symptoms of IIH mimic those of a brain tumor. The increased intracranial pressure can cause swelling of the nerve fibers that connect the eye to the brain, known as the optic nerve. The swelling can result in vision loss. Medicines often can reduce this pressure and symptoms such as headaches. Sometimes, surgery is necessary.

IIH can occur in children and adults, but it's most common in women of childbearing age with obesity.


Symptoms

Idiopathic intracranial hypertension (IIH), also called pseudotumor cerebri, symptoms might include:

  • Bad headaches that might begin behind the eyes.
  • A whooshing sound in your head that pulses with your heartbeat.
  • Nausea, vomiting or dizziness.
  • Vision loss.
  • Brief episodes of blindness, lasting a few seconds and affecting one or both eyes.
  • Trouble seeing to the side.
  • Double vision.
  • Seeing light flashes.
  • Neck, shoulder or back pain.

Sometimes symptoms that have resolved can return months or years later.


Causes

The cause of idiopathic intracranial hypertension is not known. If a cause is found, the condition is called secondary intracranial hypertension, rather than idiopathic.

The brain and spinal cord are surrounded by cerebrospinal fluid. The fluid cushions these vital tissues and protects them from injury. Cerebrospinal fluid is produced in the brain. It is eventually absorbed into the bloodstream at a rate that usually allows the pressure in the brain to remain constant.

When cerebrospinal fluid isn't absorbed into the bloodstream at the proper rate, pressure inside the skull increases.


Risk factors

Obesity, medicines and health conditions have been associated with idiopathic intracranial hypertension.

Obesity

Women who are obese and of childbearing age are more likely to develop idiopathic intracranial hypertension.

Medicines

Substances linked to secondary intracranial hypertension include:

  • Growth hormone.
  • A class of antibiotics called tetracyclines, particularly doxycycline and minocycline.
  • A class of medicines called vitamin A derivatives, particularly isotretinoin.

Health problems

Conditions and diseases that have been linked to secondary intracranial hypertension include:

  • Addison's disease.
  • Anemia.
  • Blood-clotting disorders.
  • Kidney disease.
  • Lupus.
  • Polycystic ovary syndrome.
  • Sleep apnea.
  • Underactive parathyroid glands.

Complications

For some people with idiopathic intracranial hypertension, their vision continues to worsen, leading to visual loss.


Dec 17, 2025

  1. Pseudotumor cerebri information page. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/disorders/all-disorders/pseudotumor-cerebri-information-page. Accessed Aug. 21, 2023.
  2. Lee AG, et al. Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis. https://www.uptodate.com/contents/search. Accessed Aug. 21, 2023.
  3. Chalif EJ, et al. Idiopathic intracranial hypertension: A comprehensive review. Otolaryngologic Clinics of North America. 2022; doi:10.1016/j.otc.2022.09.016.
  4. Wall M, et al. Idiopathic intracranial hypertension (pseudotumor cerebri): Prognosis and treatment. https://www.uptodate.com/contents/search. Accessed Aug. 21, 2023.
  5. Idiopathic intracranial hypertension (pseudotumor cerebri). American Association for Pediatric Ophthalmology and Strabismus. https://aapos.org/viewdocument/idiopathic-intracranial-hypertensio. Accessed Aug. 21, 2023.
  6. Ferri FF. Idiopathic intracranial hypertension. In: Ferri's Clinical Advisor 2024. Elsevier; 2024. https://www.clinicalkey.com. Accessed Aug. 21, 2023.
  7. Fargen KM, et al. "Idiopathic" intracranial hypertension: An update from neurointerventional research for clinicians. Cephalalgia. 2023; doi:10.1177/03331024231161323.
  8. Chen BS, et al. Expanding the clinical spectrum of idiopathic intracranial hypertension. Current Opinion in Neurology. 2023; doi:10.1097/WCO.0000000000001131.
  9. Chen BS, et al. Prevalence of incidentally detected signs of intracranial hypertension on magnetic resonance imaging and their association with papilledema. JAMA Neurology. 2021; doi:10.1001/jamaneurol.2021.0710.
  10. Fowlie AK, et al. Addison's disease presenting with idiopathic intracranial hypertension in a young female. Cureus. 2021; doi:10.7759/cureus.15195.
  11. Meagan S, et al. Idiopathic intracranial hypertension from benign to fulminant: Diagnostic and management issues. Annals of Indian Academy of Neurology. 2022; doi:10.4103/aian.aian_203_22.
  12. Forrester JV, et al. Anatomy of the eye and orbit. In: The Eye: Basic Sciences in Practice. 5th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed Aug. 24, 2023.
  13. Medical review (expert opinion). Mayo Clinic. Oct. 22, 2025.
  14. Winn HR, ed. Pseudotumor cerebri. In: Youmans and Winn Neurological Surgery. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Sept. 8, 2023.
  15. Piccus R, et al. Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension. Expert Review of Neurotherapeutics. 2023; doi:10.1080/14737175.2023.2206567.
  16. Guo X, et al. Intracranial venous pressures manometry for patients with idiopathic intracranial hypertension: Under awake setting or general anesthesia. Frontiers in Neurology. 2019; doi:10.3389/fneur.2019.00751.
  17. Lim J, et al. Stenting for venous sinus stenosis in patients with idiopathic intracranial hypertension: An updated systematic review and meta-analysis of the literature. Neurosurgery. 2024. doi:10.1227/neu.0000000000002718.

CON-20197162

3X your impact!

Your gift can go 3X as far to shape the future of cancer care.